Cell-intrinsic mechanism involving Siglec-5 associated with divergent outcomes of HIV-1 infection in human and chimpanzee CD4 T cells

[1]  J. Brenchley,et al.  Immunodeficiency lentiviral infections in natural and non-natural hosts. , 2011, Blood.

[2]  T. Chun,et al.  Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. , 2011, The Journal of clinical investigation.

[3]  Clarence Lehman,et al.  Impact of Simian Immunodeficiency Virus Infection on Chimpanzee Population Dynamics , 2010, PLoS pathogens.

[4]  P. Sharp,et al.  The evolution of HIV-1 and the origin of AIDS , 2010, Philosophical Transactions of the Royal Society B: Biological Sciences.

[5]  D. Douek,et al.  Nonprogressive and progressive primate immunodeficiency lentivirus infections. , 2010, Immunity.

[6]  A. Varki,et al.  Relative Over-Reactivity of Human versus Chimpanzee Lymphocytes: Implications for the Human Diseases Associated with Immune Activation , 2010, The Journal of Immunology.

[7]  B. Hahn,et al.  Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes. , 2009, Virology.

[8]  A. Moretta,et al.  The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. , 2009, Blood.

[9]  J. Jones,et al.  Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz , 2009, Nature.

[10]  Yang Liu,et al.  CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses , 2009, Science.

[11]  D. Montefiori,et al.  Analysis of the immune responses in chimpanzees infected with HIV type 1 isolates. , 2008, AIDS research and human retroviruses.

[12]  K. Chakrabandhu,et al.  Regulating Vav1 phosphorylation by the SHP-1 tyrosine phosphatase is a fine-tuning mechanism for the negative regulation of DISC formation and Fas-mediated cell death signaling , 2008, Cell Death and Differentiation.

[13]  Louise V Wain,et al.  Adaptation of HIV-1 to its human host. , 2007, Molecular biology and evolution.

[14]  Richard G. Jenner,et al.  Human and Simian Immunodeficiency Virus-Mediated Upregulation of the Apoptotic Factor TRAIL Occurs in Antigen-Presenting Cells from AIDS-Susceptible but Not from AIDS-Resistant Species , 2007, Journal of Virology.

[15]  Ajit Varki,et al.  Siglecs and their roles in the immune system , 2007, Nature Reviews Immunology.

[16]  A. Varki,et al.  Loss of Siglec expression on T lymphocytes during human evolution , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Simon,et al.  Sialic acid binding immunoglobulin‐like lectins may regulate innate immune responses by modulating the life span of granulocytes , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  H. Attrill,et al.  Siglec-5 (CD170) Can Mediate Inhibitory Signaling in the Absence of Immunoreceptor Tyrosine-based Inhibitory Motif Phosphorylation* , 2005, Journal of Biological Chemistry.

[19]  S. Staprans,et al.  The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines , 2004, Expert review of vaccines.

[20]  J. Heeney,et al.  In vitro susceptibility to infection with SIVcpz and HIV‐1 is lower in chimpanzee than in human peripheral blood mononuclear cells * , 2002, Journal of medical virology.

[21]  H. McClure,et al.  Progressive infection in a subset of HIV-1-positive chimpanzees. , 2000, The Journal of infectious diseases.

[22]  R. B. Swenson,et al.  Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1 , 1997, Journal of virology.

[23]  J. Heeney,et al.  Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. , 1997, Journal of immunology.

[24]  J. Heeney,et al.  Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS. , 1996, Immunology letters.

[25]  D. Baltimore,et al.  High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees , 1993, Journal of virology.

[26]  D. Gajdusek,et al.  Long-term observations of human immunodeficiency virus-infected chimpanzees. , 1993, AIDS research and human retroviruses.

[27]  P. Fultz,et al.  HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells. , 1990, Journal of immunology.

[28]  R. B. Swenson,et al.  Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome , 1986, Journal of virology.

[29]  W. Saxinger,et al.  Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. , 1984, Science.

[30]  K. V. Van Rompay.  The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies. , 2012, AIDS research and human retroviruses.

[31]  J. Mannhalter,et al.  Comparison of early events during infection of human and chimpanzeeperipheral blood mononuclear cells with HIV-1 , 1998, Archives of Virology.